DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Fibrate

Fibrate

  • Lipid Lowering Agents, Cognitive Decline, and Dementia: the Three-City Study

    Lipid Lowering Agents, Cognitive Decline, and Dementia: the Three-City Study

  • Stems for Nonproprietary Drug Names

    Stems for Nonproprietary Drug Names

  • The Effects of Statin and Fibrate Drugs on Cholesterol Metabolism And

    The Effects of Statin and Fibrate Drugs on Cholesterol Metabolism And

  • Lipid Management Protocol

    Lipid Management Protocol

  • 1 Lipid Lowering Agents, Cognitive Decline, and Dementia

    1 Lipid Lowering Agents, Cognitive Decline, and Dementia

  • UMHS Guideline Screening and Management of Lipids

    UMHS Guideline Screening and Management of Lipids

  • Metabolic Regulation by Lipid Activated Receptors by Maxwell A

    Metabolic Regulation by Lipid Activated Receptors by Maxwell A

  • Global Hypercoagulability in Patients with Schizophrenia Receiving Long-Term Antipsychotic Therapy

    Global Hypercoagulability in Patients with Schizophrenia Receiving Long-Term Antipsychotic Therapy

  • Repression of Glucocorticoid-Stimulated Angiopoietin-Like 4 Gene Transcription by Insulin

    Repression of Glucocorticoid-Stimulated Angiopoietin-Like 4 Gene Transcription by Insulin

  • Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs

    Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs

  • NLA Task Force on Statin Safety - 2014 Update

    NLA Task Force on Statin Safety - 2014 Update

  • STATIN-FIBRATE REPORT: Focus on Safety VHA Pharmacy Benefits Management-Strategic Healthcare Group and the Medical Advisory Panel

    STATIN-FIBRATE REPORT: Focus on Safety VHA Pharmacy Benefits Management-Strategic Healthcare Group and the Medical Advisory Panel

  • Borderline Hypercholesterolaemia: When to Introduce Drugs D

    Borderline Hypercholesterolaemia: When to Introduce Drugs D

  • Lipid Lowering Agents Are Associated with a Slower Cognitive Decline In

    Lipid Lowering Agents Are Associated with a Slower Cognitive Decline In

  • WO 2010/068601 Al

    WO 2010/068601 Al

  • PPARA Polymorphism Influences the Cardiovascular Benefit Of

    PPARA Polymorphism Influences the Cardiovascular Benefit Of

  • Redalyc.Utilisation of Atypical Antipsychotic Drugs in Institutionalised Elderly Persons and Prevalence of Metabolic Alterations

    Redalyc.Utilisation of Atypical Antipsychotic Drugs in Institutionalised Elderly Persons and Prevalence of Metabolic Alterations

  • Current P SYCHIATRY

    Current P SYCHIATRY

Top View
  • Antidiabetic Action of Bezafibrate in a Large Observational Database
  • Therapeutic Substitution
  • Add a Fibrate to a Statin?
  • Metformin Cuts BMI in At-Risk Teens
  • Fenofibrate-Induced Myopathy
  • Zetia® (Ezetimibe) Tablets
  • Gemfibrozil May 2012
  • Diabetic Retinopathy Tx: a Role for Fibrates and Statins?
  • UC Berkeley UC Berkeley Electronic Theses and Dissertations
  • The Effect of Bezafibrate in Preventing Glucolipid Abnormalities Induced by the Antipsychotic Risperidone
  • KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease
  • Therapeutic Class Overview Bile Acid Sequestrants
  • No Proof Fibrate Drugs Reduce Heart Risk in Diabetes Patients on Statins 10 August 2011
  • Emerging Strategies of Targeting Lipoprotein Lipase for Metabolic and Cardiovascular Diseases
  • Lipid-Lowering Drugs and Risk of New- Onset Diabetes: a Cohort Study Using Japanese Healthcare Data Linked to Clinical Data for Health Screening
  • Protocol for a Pharmacogenomic Study on Individualised Antipsychotic Drug Treatment for Patients with Schizophrenia
  • Medicines for Your Heart
  • Glycyrrhizic Acid Improved Lipoprotein Lipase Expression, Insulin Sensitivity


© 2024 Docslib.org    Feedback